Apr 24, 2026
Boehringer Ingelheim Launches AI and Machine Learning Centre in London
Boehringer Ingelheim has inaugurated a new AI and machine learning centre in London, reflecting a significant investment in enhancing drug discovery and patient care.Situated in King’s Cross, this facility is part of a £150 million ($202.7 million) investment over the next decade, aimed at embedding AI technologies into the company's research and development processes. The centre's primary focus will be on creating computational models that deepen the understanding of disease biology, ultimately